vs
Side-by-side financial comparison of Amneal Pharmaceuticals, Inc. (AMRX) and Howard Hughes Holdings Inc. (HHH). Click either name above to swap in a different company.
Amneal Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($722.5M vs $235.9M, roughly 3.1× Howard Hughes Holdings Inc.). Amneal Pharmaceuticals, Inc. runs the higher net margin — 10.8% vs 3.4%, a 7.4% gap on every dollar of revenue. On growth, Howard Hughes Holdings Inc. posted the faster year-over-year revenue change (18.4% vs 3.9%). Over the past eight quarters, Amneal Pharmaceuticals, Inc.'s revenue compounded faster (1.5% CAGR vs -13.8%).
Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States.
Howard Hughes Holdings Inc., formerly the Howard Hughes Corporation, is a real estate development and management company based in The Woodlands, Texas. It was formed in 2010 as a spin-off from General Growth Properties (GGP). Most of its holdings are focused on several master-planned communities. It took its name from the original Howard Hughes Corporation, which had developed the planned community of Summerlin, Nevada, and later became a subsidiary of GGP.
AMRX vs HHH — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $722.5M | $235.9M |
| Net Profit | $78.0M | $8.1M |
| Gross Margin | 44.3% | — |
| Operating Margin | 19.6% | 121.6% |
| Net Margin | 10.8% | 3.4% |
| Revenue YoY | 3.9% | 18.4% |
| Net Profit YoY | 410.5% | -25.6% |
| EPS (diluted) | $0.19 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $722.5M | $235.9M | ||
| Q4 25 | $814.3M | $624.4M | ||
| Q3 25 | $784.5M | $390.2M | ||
| Q2 25 | $724.5M | $260.9M | ||
| Q1 25 | $695.4M | $199.3M | ||
| Q4 24 | $730.5M | $935.0M | ||
| Q3 24 | $702.5M | $327.1M | ||
| Q2 24 | $701.8M | $317.4M |
| Q1 26 | $78.0M | $8.1M | ||
| Q4 25 | $35.1M | $6.0M | ||
| Q3 25 | $2.4M | $119.5M | ||
| Q2 25 | $22.4M | $-12.1M | ||
| Q1 25 | $12.2M | $10.5M | ||
| Q4 24 | $-31.1M | $156.3M | ||
| Q3 24 | $-156.0K | $72.8M | ||
| Q2 24 | $6.0M | $21.1M |
| Q1 26 | 44.3% | — | ||
| Q4 25 | 36.5% | — | ||
| Q3 25 | 34.9% | — | ||
| Q2 25 | 39.5% | — | ||
| Q1 25 | 36.8% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 38.4% | — | ||
| Q2 24 | 35.6% | — |
| Q1 26 | 19.6% | 121.6% | ||
| Q4 25 | 13.8% | 4.2% | ||
| Q3 25 | 9.0% | 48.6% | ||
| Q2 25 | 15.4% | 26.0% | ||
| Q1 25 | 14.4% | 24.0% | ||
| Q4 24 | 10.4% | 33.5% | ||
| Q3 24 | 12.6% | 60.6% | ||
| Q2 24 | 13.6% | 20.4% |
| Q1 26 | 10.8% | 3.4% | ||
| Q4 25 | 4.3% | 1.0% | ||
| Q3 25 | 0.3% | 30.6% | ||
| Q2 25 | 3.1% | -4.7% | ||
| Q1 25 | 1.8% | 5.3% | ||
| Q4 24 | -4.3% | 16.7% | ||
| Q3 24 | -0.0% | 22.2% | ||
| Q2 24 | 0.9% | 6.6% |
| Q1 26 | $0.19 | $0.14 | ||
| Q4 25 | $0.10 | $0.20 | ||
| Q3 25 | $0.01 | $2.02 | ||
| Q2 25 | $0.07 | $-0.22 | ||
| Q1 25 | $0.04 | $0.21 | ||
| Q4 24 | $-0.10 | $3.14 | ||
| Q3 24 | $0.00 | $1.46 | ||
| Q2 24 | $0.02 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $197.7M | $1.8B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $3.8B |
| Total Assets | $3.5B | $11.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $197.7M | $1.8B | ||
| Q4 25 | $282.0M | $1.5B | ||
| Q3 25 | $201.2M | $1.5B | ||
| Q2 25 | $71.5M | $1.4B | ||
| Q1 25 | $59.2M | $493.7M | ||
| Q4 24 | $110.6M | $596.1M | ||
| Q3 24 | $74.0M | $400.7M | ||
| Q2 24 | $43.8M | $436.8M |
| Q1 26 | — | — | ||
| Q4 25 | $2.6B | $5.1B | ||
| Q3 25 | $2.6B | — | ||
| Q2 25 | $2.2B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.4B | $5.1B | ||
| Q3 24 | $2.4B | — | ||
| Q2 24 | $2.4B | — |
| Q1 26 | — | $3.8B | ||
| Q4 25 | $-70.8M | $3.8B | ||
| Q3 25 | $-109.5M | $3.8B | ||
| Q2 25 | $-112.1M | $3.6B | ||
| Q1 25 | $-131.7M | $2.8B | ||
| Q4 24 | $-109.3M | $2.8B | ||
| Q3 24 | $-93.4M | $2.6B | ||
| Q2 24 | $-57.5M | $3.0B |
| Q1 26 | $3.5B | $11.2B | ||
| Q4 25 | $3.7B | $10.6B | ||
| Q3 25 | $3.6B | $10.7B | ||
| Q2 25 | $3.4B | $10.3B | ||
| Q1 25 | $3.4B | $9.3B | ||
| Q4 24 | $3.5B | $9.2B | ||
| Q3 24 | $3.5B | $9.4B | ||
| Q2 24 | $3.5B | $9.9B |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.35× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.85× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMRX
Segment breakdown not available.
HHH
| Rental revenue | $113.5M | 48% |
| Master Planned Communities land sales | $99.6M | 42% |
| Other revenues | $11.0M | 5% |
| Builder price participation | $8.7M | 4% |
| Condominium rights and unit sales | $3.1M | 1% |
